Search - tctmd.com

Displaying 181 - 200 of 399

Sort: Relevancy | Date

News Opinion Editor's Corner

ISCHEMIA Questions? Some Answers From David Maron

Shelley Wood

December 09, 2019

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Daily News

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Michael O'Riordan

November 29, 2019

News Conference News AHA 2019

Complete Revascularization Benefits May Be Due to Stenting Vulnerable Plaques

Todd Neale

November 21, 2019

News Conference News AHA 2019

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Yael L. Maxwell

November 17, 2019

News Daily News

DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis

Michael O'Riordan

October 17, 2019

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2019

Shelley Wood

October 01, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

Presentation TCT 2019

STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

Presenter: Aditya Kapoor

September 28, 2019

News Conference News TCT 2019

EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG

Marcus A. Banks

September 28, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Conference News ESC 2019

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

Todd Neale

September 03, 2019

News Conference News ESC 2019

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

Todd Neale

September 02, 2019

News Conference News ESC 2019

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Michael O'Riordan

September 01, 2019

News Daily News

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Michael O'Riordan

August 22, 2019

News Daily News

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

Shelley Wood

August 05, 2019

News Daily News

CV Risk Factors in Youth May Prove Indelible for Later CAD

Marcus A. Banks

July 17, 2019

News Conference News EuroPCR 2019

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Caitlin E. Cox

June 06, 2019

News Conference News SCAI 2019

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Yael L. Maxwell

May 24, 2019

Advertisement

ISCHEMIA Questions? Some Answers From David Maron

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Complete Revascularization Benefits May Be Due to Stenting Vulnerable Plaques

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

TCTMD’s Top 10 Most Popular Stories for September 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

CV Risk Factors in Youth May Prove Indelible for Later CAD

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content